EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-Atherogenic Actions of Pomegranate Polyphenol Punicalagin and Its Metabolites: In Vitro Effects on Vascular Cells and In Vivo Atheroprotection by Urolithin A via Anti-Inflammatory and Plaque-Stabilising Mechanisms

Sulaiman Alalawi iD, Daniah Rifqi iD, Alaa Alhamadi, Reem Alotibi, Fahad Alradi, Nouf Alshehri, Yee-Hung Chan iD, Jing Chen, Faizah Albalawi, Sarab Taha, Nabras Al-Mahrami, Irina A Guschina iD und 2 weitere

Antioxidants · 20.04.2026 · 15 (4) · 507

DOI: 10.3390/antiox15040507 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 20.04.2026. Verfasst von Sulaiman Alalawi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cardiff School of Biosciences, Cardiff University, Sir Martin Evans Building, Museum Avenue, Cardiff CF10 3AX, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Sultanate of Oman.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nutraceuticals are emerging as promising agents for the prevention and treatment of atherosclerosis, particularly in light of the limitations associated with current pharmacotherapies. Pomegranate-derived polyphenols, especially punicalagin (PC), possess multiple cardioprotective properties. However, their direct biological effects are constrained by poor absorption and low bioavailability. Instead, many of their actions are mediated by gut microbiota-derived metabolites known as urolithins. Despite this, the roles of PC and its metabolites in atherosclerosis remain inadequately defined. The objective of this study was to investigate the anti-atherogenic effects and underlying mechanisms of PC and its major metabolites—ellagic acid and urolithins A, B, C, and D—using in vitro and in vivo approaches. In vitro, these compounds broadly inhibited key pro-atherogenic processes in macrophages and endothelial cells, including reactive oxygen species production and inflammatory gene expression, with notable metabolite-specific differences. Urolithin A (UA), identified as the most effective compound, was further evaluated in LDL receptor-deficient mice fed a high-fat diet. UA supplementation improved peripheral blood immune cell profile, reduced atherosclerotic plaque burden and inflammation, and enhanced markers of plaque stability. RNA sequencing of the thoracic aorta revealed key molecular pathways underlying the protective actions of UA. Collectively, these findings highlight the therapeutic potential of PC-derived metabolites, particularly UA, in combating atherosclerosis and support the need for future human clinical studies.

Schlagwörter

Stichwörter der Autor:innen

atherosclerosisgene expressioninflammationmacrophagesnutraceuticalsplaque stabilitypunicalaginurolithins

Autor:innen und Institutionen

  • Cardiff School of Biosciences, Cardiff University, Sir Martin Evans Building, Museum Avenue, Cardiff CF10 3AX, UK.
  • Ministry of Health, P.O. Box 393, Muscat 100, Oman.
  • European Cancer Stem Cell Research Institute, Cardiff School of Biosciences, Cardiff University, Hadyn Ellis Building, Maindy Road, Cardiff CF24 4HQ, UK.
  • Medical Laboratory Sciences, Health Sciences, Oman College of Health Sciences, P.O. Box 3720, Muscat 112, Oman.
  • Division of Infection and Immunity, School of Medicine, Cardiff University, Henry Wellcome Building, Heath Park, Cardiff CF14 4XN, UK.

ORCID-Profile: Sulaiman Alalawi, Daniah Rifqi, Yee-Hung Chan, Irina A Guschina, Dipak P Ramji

Förderung

  • British Heart Foundation
  • Sultanate of Oman

Zitieren

APA

Alalawi, S., Rifqi, D., Alhamadi, A., Alotibi, R., Alradi, F., Alshehri, N., Chan, Y. H., Chen, J., Albalawi, F., Taha, S., Al-Mahrami, N., Guschina, I. A., Hughes, T. R., & Ramji, D. P. (2026). Anti-Atherogenic Actions of Pomegranate Polyphenol Punicalagin and Its Metabolites: In Vitro Effects on Vascular Cells and In Vivo Atheroprotection by Urolithin A via Anti-Inflammatory and Plaque-Stabilising Mechanisms. Antioxidants, 15(4), 507. https://doi.org/10.3390/antiox15040507

Vancouver

Alalawi S, Rifqi D, Alhamadi A, Alotibi R, Alradi F, Alshehri N, et al. Anti-Atherogenic Actions of Pomegranate Polyphenol Punicalagin and Its Metabolites: In Vitro Effects on Vascular Cells and In Vivo Atheroprotection by Urolithin A via Anti-Inflammatory and Plaque-Stabilising Mechanisms. Antioxidants. 2026;15(4):507. doi:10.3390/antiox15040507

BibTeX
@article{Alalawi2026,
  author = {Alalawi, Sulaiman and Rifqi, Daniah and Alhamadi, Alaa and Alotibi, Reem and Alradi, Fahad and Alshehri, Nouf and Chan, Yee-Hung and Chen, Jing and Albalawi, Faizah and Taha, Sarab and Al-Mahrami, Nabras and Guschina, Irina A and Hughes, Timothy R and Ramji, Dipak P},
  title = {Anti-Atherogenic Actions of Pomegranate Polyphenol Punicalagin and Its Metabolites: In Vitro Effects on Vascular Cells and In Vivo Atheroprotection by Urolithin A via Anti-Inflammatory and Plaque-Stabilising Mechanisms},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {4},
  pages = {507},
  doi = {10.3390/antiox15040507}
}
Kostenlos starten →